Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

GALECTIN THERAPEUTICS INC.

(GALT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 141163128111111-
Enterprise Value (EV)1 141163128111111111
P/E ratio -9,03x-7,33x-5,46x-3,17x-2,46x-2,37x
Yield ------
Capitalization / Revenue ------
EV / Revenue ------
EV / EBITDA ------
Price to Book ------
Nbr of stocks (in thousands) 41 13756 88657 07759 34159 341-
Reference price (USD) 3,432,862,241,871,871,87
Announcement Date 03/06/201903/16/202003/31/2021---
1 USD in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 ------
EBITDA ------
Operating profit (EBIT)1 -13,6-13,4-23,4-34,0-47,8-57,6
Operating Margin ------
Pre-Tax Profit (EBT)1 -13,9-13,3-23,5-34,7-48,8-58,2
Net income1 -15,0-20,2-23,6-34,9-48,9-58,2
Net margin ------
EPS2 -0,38-0,39-0,41-0,59-0,76-0,79
Dividend per Share ------
Announcement Date 03/06/201903/16/202003/31/2021---
1 USD in Million
2 USD
Previous periodNext period
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2
Net sales1 ------
EBITDA ------
Operating profit (EBIT)1 -6,32-8,19-8,24-11,2-11,7-11,7
Operating Margin ------
Pre-Tax Profit (EBT)1 -6,34-8,45-8,52-11,4-11,9-11,9
Net income1 -6,34-8,51-8,56-11,5-11,9-12,0
Net margin ------
EPS2 -0,11-0,15-0,14-0,19-0,20-0,18
Dividend per Share ------
Announcement Date 05/17/202108/16/202111/15/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt ------
Net Cash position ------
Leverage (Debt / EBITDA) ------
Free Cash Flow -10,2-10,8----
ROE (Net Profit / Equities) ------
Shareholders' equity1 ------
ROA (Net Profit / Asset) ------
Assets1 ------
Book Value Per Share ------
Cash Flow per Share ------
Capex ------
Capex / Sales ------
Announcement Date 03/06/201903/16/202003/31/2021---
1 USD in Million
Previous periodNext period
Key data
Capitalization (USD) 110 968 240
Number of employees 6
Free-Float 70,5%
Free-Float capitalization (USD) 78 236 096
Avg. Exchange 20 sessions (USD) 361 901
Average Daily Capital Traded 0,33%
EPS & Dividend